GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Proteome Sciences PLC (LSE:PRM) » Definitions » ROIC %

Proteome Sciences (LSE:PRM) ROIC % : -16.24% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Proteome Sciences ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Proteome Sciences's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was -16.24%.

As of today (2024-06-24), Proteome Sciences's WACC % is 4.80%. Proteome Sciences's ROIC % is -9.25% (calculated using TTM income statement data). Proteome Sciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Proteome Sciences ROIC % Historical Data

The historical data trend for Proteome Sciences's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteome Sciences ROIC % Chart

Proteome Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.15 4.16 1.54 10.67 -8.93

Proteome Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.81 2.64 18.08 -2.04 -16.24

Competitive Comparison of Proteome Sciences's ROIC %

For the Diagnostics & Research subindustry, Proteome Sciences's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteome Sciences's ROIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's ROIC % distribution charts can be found below:

* The bar in red indicates where Proteome Sciences's ROIC % falls into.



Proteome Sciences ROIC % Calculation

Proteome Sciences's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-1.621 * ( 1 - -1.03% )/( (17.352 + 19.319)/ 2 )
=-1.6376963/18.3355
=-8.93 %

where

Proteome Sciences's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-2.916 * ( 1 - 0.32% )/( (16.47 + 19.319)/ 2 )
=-2.9066688/17.8945
=-16.24 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proteome Sciences  (LSE:PRM) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Proteome Sciences's WACC % is 4.80%. Proteome Sciences's ROIC % is -9.25% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Proteome Sciences ROIC % Related Terms

Thank you for viewing the detailed overview of Proteome Sciences's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteome Sciences (LSE:PRM) Business Description

Traded in Other Exchanges
Address
Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.

Proteome Sciences (LSE:PRM) Headlines

From GuruFocus

Perimeter Announces Date for Third Quarter 2021 Earnings Call

By PRNewswire PRNewswire 12-02-2021

Perimeter Solutions Reports Third Quarter 2021 Results

By PRNewswire PRNewswire 12-14-2021

Top 5 2nd Quarter Trades of Stanley Capital Management, LLC

By GuruFocus Research GuruFocus Editor 08-16-2022

Perimeter Solutions Sa (PRM) COO Ernest C. Kremling Ii Bought $1.5 million of Shares

By GuruFocus Research GuruFocus Editor 11-11-2021

Perimeter Announces Date for Fourth Quarter 2021 Earnings Call

By PRNewswire PRNewswire 03-04-2022

EQUITABLE TRUST CO Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-21-2023

Perimeter Announces Date for Third Quarter 2022 Earnings Call

By PRNewswire PRNewswire 10-24-2022